Workflow
Beauty
icon
Search documents
The Beauty Health Company (SKIN) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-10 16:43
Core Viewpoint - The Beauty Health Company held its Q1 2025 earnings conference call to discuss financial results and future outlook [1][3]. Group 1: Company Overview - The Beauty Health Company is publicly traded on NASDAQ under the ticker SKIN [1]. - The conference call featured key executives including Marla Beck (President and CEO) and Mike Monahan (CFO) [3]. Group 2: Financial Reporting - The company released its Q1 2025 financial results earlier in the day, which are available on its corporate website [3]. - The call included discussions on non-GAAP financial measures, with reconciliations provided in the earnings press release [5].
Ulta Beauty:盈利拐点催化,首次评级为“买入”
美股研究社· 2025-05-09 11:43
如果 Ulta 的短期痛苦实际上是其长期恢复美容零售主导地位的确切催化剂呢? 分析师预测2025财年盈利将有针对性地回落,预计每股收益为22.70美元(管理层指引中值), 较2024财年下降10.4%,原因是Ulta正在消化"Ulta Beauty Unleashed"带来的巨额投资。相比之 下,市场普遍预期2026财年每股收益为22.84美元;复苏会更快、更强劲——预测2026财年每股 收益为24.50美元,比华尔街预期高出7.3%,这得益于今年运营方面的不利因素将成为竞争的有 利因素(华尔街普遍预期)。为什么会有上涨? 作者 | Moretus Research 编译 | 华尔街大事件 Ulta Beauty(NASDAQ:ULTA)是美国最大的专业美妆零售网络,通过 1,300 多家门店和强大的 数字渠道提供化妆品、护肤品、沙龙服务和自有品牌产品。分析师给予 " 买入"评级的理由如 下: 1) 由于 Ulta在其"Ulta Beauty Unleashed"战略中吸收了大量投资,我们预测 25 财年每股收益将 有目的地收缩 10.4%,这为 26 财年每股收益的爆炸性复苏奠定了基础,分析师预测该复苏将比 ...
Yatsen to Announce First Quarter 2025 Financial Results on May 16, 2025
Prnewswire· 2025-05-09 09:00
Core Viewpoint - Yatsen Holding Limited, a leading beauty group based in China, is set to release its unaudited financial results for Q1 2025 on May 16, 2025, before U.S. market opening [1]. Financial Results Announcement - The financial results will be discussed in a conference call scheduled for May 16, 2025, at 7:30 A.M. U.S. Eastern Time [2]. - The call can be accessed via multiple toll-free numbers for the U.S., international, and Mainland China listeners [2]. Company Overview - Yatsen Holding Limited was founded in 2016 and has launched and acquired several beauty brands, including Perfect Diary, Little Ondine, and DR.WU [3]. - Perfect Diary is recognized as one of the leading color cosmetics brands in China based on retail sales value [3]. - The company engages with customers through both online and offline channels, maintaining a strong presence across major e-commerce and social platforms in China [3].
Ulta Beauty: Earnings Inflection Catalyzed, Initiate At Buy
Seeking Alpha· 2025-05-09 02:53
Group 1 - The article initiates coverage on Ulta Beauty (NASDAQ: ULTA) with a Buy rating and a price target of $432.81, highlighting it as the largest dedicated beauty retail network in the U.S. with over 1,300 stores and strong digital channels [1] - Ulta Beauty offers a range of products and services including cosmetics, skincare, salon services, and private-label products, indicating a diversified business model [1] - Moretus Research employs a structured framework to identify companies with durable business models and mispriced cash flow potential, focusing on U.S. public markets [1] Group 2 - The research emphasizes rigorous fundamental analysis combined with a judgment-driven process, aiming to provide clarity and actionable insights for investors [1] - Valuation methods are based on sector-relevant multiples tailored to each company's business model, emphasizing comparability and simplicity [1] - Moretus Research targets underappreciated companies undergoing structural changes or temporary dislocations, which can lead to asymmetric returns for investors [1]
Beauty Health (SKIN) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-09 00:35
Core Insights - The Beauty Health Company (SKIN) reported a revenue of $69.6 million for the quarter ended March 2025, reflecting a year-over-year decline of 14.5% [1] - The earnings per share (EPS) was -$0.08, an improvement from -$0.10 in the same quarter last year, with a positive surprise of 38.46% compared to the consensus estimate of -$0.13 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $63.12 million by 10.26% [1] Financial Performance Metrics - Total delivery systems sold reached 862, surpassing the average estimate of 573 based on two analysts [4] - The active install base was reported at 35,014, slightly below the average estimate of 35,090 [4] - Geographic revenue breakdown showed: - Americas: $46.30 million, exceeding the estimate of $43.49 million, but down 8% year-over-year [4] - EMEA: $15 million, above the estimate of $13.60 million, with a year-over-year decline of 21.5% [4] - Asia Pacific: $8.30 million, surpassing the estimate of $6.98 million, down 30.8% year-over-year [4] - Delivery Systems Net Sales were $20.20 million, exceeding the estimate of $14.30 million, but down 43.6% year-over-year [4] - Consumables Net Sales reached $49.40 million, slightly above the estimate of $48.24 million, reflecting an increase of 8.3% year-over-year [4] Stock Performance - Shares of Beauty Health have increased by 31.5% over the past month, outperforming the Zacks S&P 500 composite, which rose by 11.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
Olaplex (OLPX) - 2025 Q1 - Earnings Call Presentation
2025-05-08 15:24
Q1 2025 EARNINGS – MAY 8, 2025 DISCLAIMER General Disclaimer This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities of Olaplex Holdings, Inc. (the "Company"), nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward Looking Statements This presentation includes certain forwar ...
Sally Beauty (SBH) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2025-05-08 14:21
In its upcoming report, Sally Beauty (SBH) is predicted by Wall Street analysts to post quarterly earnings of $0.39 per share, reflecting an increase of 11.4% compared to the same period last year. Revenues are forecasted to be $901.1 million, representing a year-over-year decrease of 0.8%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Ahead of a comp ...
Olaplex (OLPX) - 2025 Q1 - Earnings Call Transcript
2025-05-08 14:02
Olaplex (OLPX) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Allison Malkin - PartnerAmanda Baldwin - CEO & DirectorCatherine Dunleavy - COO & CFOJonna Kim - DirectorSydney Wagner - Equity Research Senior Associate - Beauty & Personal CareKate Grafstein - VP - Equity ResearchDana Telsey - CEO and Chief Research Officer Conference Call Participants Susan Anderson - Managing Director & Senior AnalystShovana Chowdhury - AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research An ...
OLAPLEX Reports First Quarter 2025 Results
Globenewswire· 2025-05-08 10:45
New York, NY, May 08, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the first quarter ended March 31, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We had a solid start to the year as the quarter marked continued progress on our transformation and our Bonds and Beyond strategy, with first quarter sales coming in ahead of our expectations. As we look ahead, we believe in our ability to navigate the dyna ...
Coty(COTY) - 2025 Q3 - Earnings Call Transcript
2025-05-07 13:02
Coty (COTY) Q3 2025 Earnings Call May 07, 2025 08:00 AM ET Company Participants Robert Ottenstein - Senior Managing Director & PartnerSue Nabi - CEOFilippo Falorni - Director - Equity ResearchLaurent Mercier - CFOBonnie Herzog - Managing Director Olivia Tong - Managing DirectorAshley Helgans - Senior Vice PresidentAnna Lizzul - Vice President - Equity Research Conference Call Participants Susan Anderson - Managing Director & Senior AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - ...